Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $965.14 | 54 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $150.24 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $132.89 | 8 | $0 (2024) |
| Celgene Corporation | $100.12 | 7 | $0 (2018) |
| Janssen Biotech, Inc. | $89.30 | 6 | $0 (2024) |
| Genentech USA, Inc. | $63.35 | 4 | $0 (2020) |
| Galderma Laboratories, L.P. | $61.64 | 5 | $0 (2023) |
| ABBVIE INC. | $46.90 | 2 | $0 (2022) |
| Merz North America, Inc. | $43.92 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $34.03 | 3 | $0 (2017) |
| GENZYME CORPORATION | $33.80 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $255.06 | 8 | SUN PHARMACEUTICAL INDUSTRIES INC. ($121.36) |
| 2023 | $79.89 | 4 | GENZYME CORPORATION ($33.80) |
| 2022 | $27.36 | 1 | ABBVIE INC. ($27.36) |
| 2020 | $51.03 | 3 | EPI Health, LLC ($20.74) |
| 2019 | $186.83 | 12 | Regeneron Healthcare Solutions, Inc. ($66.37) |
| 2018 | $150.50 | 11 | Sun Pharmaceutical Industries Inc. ($28.88) |
| 2017 | $214.47 | 15 | Celgene Corporation ($85.12) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Immunology | ||||||
| 10/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Immunology | ||||||
| 06/25/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: DERMATOLOGY | ||||||
| 05/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Biological) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: CNS | ||||||
| 04/26/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Immunology | ||||||
| 01/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: DERMATOLOGY | ||||||
| 10/26/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/28/2023 | Galderma Laboratories, L.P. | DYSPORT | Food and Beverage | In-kind items and services | $13.58 | General |
| 02/22/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: Immunology | ||||||
| 06/02/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: IMMUNOLOGY | ||||||
| 03/02/2020 | EPI Health, LLC | Sitavig (Drug), Cloderm, Minolira 105mg | Food and Beverage | Cash or cash equivalent | $20.74 | General |
| Category: Dermatology | ||||||
| 02/27/2020 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: BioOncology | ||||||
| 02/06/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/17/2019 | Almirall LLC | Aczone (Drug) | Food and Beverage | Cash or cash equivalent | $11.91 | General |
| Category: Dermatology | ||||||
| 10/07/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/18/2019 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: BioOncology | ||||||
| 09/11/2019 | DERMIRA, INC. | — | Food and Beverage | In-kind items and services | $13.58 | General |
| 07/11/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/05/2019 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: BioOncology | ||||||
| 05/21/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Immunology | ||||||
| 04/25/2019 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,255 | 2,064 | $2.7M | $622,993 |
| 2022 | 26 | 1,454 | 1,894 | $2.0M | $555,145 |
| 2021 | 24 | 1,443 | 1,988 | $1.6M | $576,098 |
| 2020 | 22 | 1,207 | 1,825 | $1.3M | $457,060 |
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 394 | 472 | $909,916 | $190,808 | 21.0% |
| Q4190 | Artacent ac, per square centimeter | Office | 2023 | 21 | 360 | $600,177 | $156,846 | 26.1% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 274 | 413 | $480,802 | $127,250 | 26.5% |
| 14301 | Repair of wound by transferring skin, 30.1-60.0 sq cm | Office | 2023 | 26 | 26 | $80,797 | $21,116 | 26.1% |
| 14061 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 26 | 26 | $73,249 | $19,033 | 26.0% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 25 | 25 | $71,743 | $18,335 | 25.6% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 36 | 44 | $80,075 | $17,672 | 22.1% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 20 | 20 | $53,466 | $13,972 | 26.1% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 87 | 90 | $81,592 | $11,319 | 13.9% |
| 15120 | Partial thickness self skin graft to face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 100.0 sq cm or 1% body area for infants and children, or less | Office | 2023 | 16 | 16 | $38,968 | $9,873 | 25.3% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 15 | 24 | $27,069 | $7,074 | 26.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 41 | 42 | $36,523 | $5,986 | 16.4% |
| 15275 | Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | Office | 2023 | 17 | 43 | $19,727 | $4,436 | 22.5% |
| 12053 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | Office | 2023 | 28 | 28 | $28,855 | $4,119 | 14.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 55 | 80 | $15,316 | $2,695 | 17.6% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 13 | 13 | $15,957 | $2,382 | 14.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 37 | 46 | $13,275 | $2,222 | 16.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 41 | 54 | $8,685 | $2,130 | 24.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 24 | $12,247 | $2,016 | 16.5% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 16 | 16 | $13,076 | $1,815 | 13.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 20 | $5,184 | $1,073 | 20.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 32 | 182 | $3,401 | $819.97 | 24.1% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 443 | 558 | $868,180 | $225,391 | 26.0% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 301 | 443 | $416,060 | $139,543 | 33.5% |
| 14301 | Repair of wound by transferring skin, 30.1-60.0 sq cm | Office | 2022 | 35 | 35 | $90,339 | $29,437 | 32.6% |
About Dr. Brian Biernat, MD
Dr. Brian Biernat, MD is a MOHS-Micrographic Surgery healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386629640.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Biernat, MD has received a total of $965.14 in payments from pharmaceutical and medical device companies, with $255.06 received in 2024. These payments were reported across 54 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($965.14).
As a Medicare-enrolled provider, Biernat has provided services to 5,359 Medicare beneficiaries, totaling 7,771 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Westerville, OH
- Active Since 12/09/2005
- Last Updated 08/13/2020
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1386629640
Products in Payments
- DUPIXENT (Biological) $152.00
- ILUMYA (Biological) $121.36
- STELARA (Biological) $66.64
- Erivedge (Biological) $63.35
- COSENTYX (Biological) $34.03
- SILIQ (Drug) $27.88
- SKYRIZI (Biological) $27.36
- Xeomin (Biological) $27.34
- ADBRY (Biological) $24.81
- TREMFYA (Drug) $22.66
- Sitavig (Drug) $20.74
- RHOFADE (Drug) $20.27
- Humira (Biological) $19.54
- Bimzelx (Biological) $18.39
- TALTZ (Drug) $18.15
- XEOMIN (Biological) $16.58
- CYLTEZO (Biological) $15.68
- Otezla (Drug) $15.00
- LIBTAYO (Biological) $14.69
- ILUMYA (tildrakizumab-asmn) injection (Biological) $14.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.